All News

FDA-Building_1.png

Problems at the FDA

d Jack Cush, MD

"While the Food and Drug Administration decision on new drugs usually follows the recommendations of the advisory committee..."; this oft used proviso is used to either indicate a pending FDA decision or an FDA decision that is contrary to the recommendation of the advisory committee co

Read Article
artificial intelligence machine learning computer

Artificial intelligence brings clarity to early bony changes in inflammatory arthritis

d David Liew, FRACP

Subtle early bony changes in inflammatory arthritis can be hard even for experienced rheumatologists to interpret, even though they have traditionally been considered to become disease-defining as they progress.

Read Article
depression oh no HA

Psoriatic arthritis mortality & morbidities

d Paul Studenic, MD, PhD

Psoriatic arthritis (PsA) is a chronic condition with manifold clinical presentations. Health issues may be far beyond the classical associated conditions like uveitis, enthesitis etc. The current study of Tillett et al (OP0231) assessed comorbidities and patient characteristics comparing psoriasis patients with or without PsA.

Read Article
pregnant, pregnancy, mother, fertility

Current approach to lupus and pregnancy

d Robert Chao, MD

All of us are extremely cautious with lupus patients when it comes to pregnancy. Presentation 6888 (Common issues in pregnancy management in lupus and anti-phospholipid syndrome by Dr. Rebecca Fischer-Betz) was an excellent overview of our current approach to lupus and pregnancy. 

Read Article
EULAR 2021 Best Abstracts - Day 1 The RheumNow faculty reporters have been scouring the Posters and Presentations from virtual EULAR 2021. Several of these are novel enough to be worthy of your consideration. https://t.co/fmfYrey9wf https://t.co/V48Nuy4JsN

Links:

Dr. John Cush RheumNow ( View Tweet)
Why do female counterparts axSpA patients report worsening outcomes and worsening scores compared to their male counterparts? https://t.co/6hXp4Lemyk https://t.co/RTuhATrtG9

Links:

Dr. John Cush RheumNow ( View Tweet)
Psoriatic arthritis (PsA) is a chronic condition with manifold clinical presentations. Health issues may be far beyond the classical associated conditions like uveitis, enthesitis etc. https://t.co/zHfeaiiG93

Links:

Dr. John Cush RheumNow ( View Tweet)

Combination disease modifying antirheumatic drug (DMARD) therapy may not be only for rheumatoid arthritis; combining disease modifying agents may be the path to better renal response. Read more. https://t.co/0d1bxBlUS0 https://t.co/OZzJKwNJ4i

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatoid arthritis in either partner can affect fertility and pregnancy outcomes. Dr. Kay discusses abstract OP0210, abstract OP0212 and abstract OP0211 presented at the virtual EULAR meeting. https://t.co/Y9uVBGmxcP https://t.co/YVz08q67gc

Links:

Dr. John Cush RheumNow ( View Tweet)
Miss something at #EULAR2021? Check out the Day 3 report. https://t.co/X7zxsKW8eL https://t.co/IDvukvfN9J

Links:

Dr. John Cush RheumNow ( View Tweet)
Abatacept in RA ILD Dr. Conway ( @RichardPAConway) discusses abstract POS0595 at the virtual #EULAR2021 meeting. https://t.co/rpVuHOkS5w https://t.co/7pNzh6sb7a

Links:

Dr. John Cush RheumNow ( View Tweet)
How has the pandemic impacted rheumatology training? Dr. Kathryn Dao ( @KDAO2011 ) and Dr. Young discuss. https://t.co/zYPd4hDzjV https://t.co/uuqDRXHWsN

Links:

Dr. John Cush RheumNow ( View Tweet)
What about Babies of Patients with Inflammatory Arthritis? Dr. Janet Pope ( @Janetbirdope) shares the results from study OP0211. #EULAR2021 https://t.co/odLknwNlMv https://t.co/AmsaSg9Gwe

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting. Listen to the RheumNow podcast and catch up on #EULAR2021. https://t.co/qiSq8cVtuk https://t.co/FVy453hvVN

Links:

Dr. John Cush RheumNow ( View Tweet)
The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheums’ offices everywhere this year, and at #EULAR2021, data presented from Israel, has provided much-needed answers. https://t.co/PUa6deflTy https://t.co/cs4MwnIcdR

Links:

Dr. John Cush RheumNow ( View Tweet)
Exciting news for lupus treatment. Dr. Kathryn Dao ( @KDAO2011) discusses Iberdomide for lupus. #EULAR2021 https://t.co/x5tWgwBMaB https://t.co/HIaXbgRRuN

Links:

Dr. John Cush RheumNow ( View Tweet)
Popular article alert! New GRAPPA 2021 PsO and PsA Treatment Recommendations Dr. Rachel Tate ( @uptoTate ) shares insights from abstract #OP0229 at #EULAR2021. https://t.co/AnHQGA8aKs https://t.co/9Acnzofiu4

Links:

Dr. John Cush RheumNow ( View Tweet)
Do Patients on Upadacitinib Need Labs? Dr. Janet Pope from Canada, discusses abstract OP00128 presented at the virtual #EULAR2021. https://t.co/mxPzeQXZk7 https://t.co/qz9KiYfTCu

Links:

Dr. John Cush RheumNow ( View Tweet)
Do B-cell targeted therapies still have a place for the treatment of Sjogren’s? https://t.co/96sv3beMvG https://t.co/oabgmkAfGk

Links:

Dr. John Cush RheumNow ( View Tweet)
RA and Dementia: Trying to Forget the Problem? Dr. David Liew ( @drdavidliew) reviews abstract OP0216, "Trends in Occurrence of Dementia in Patients with Rheumatoid Arthritis: A Population-Based Cohort Study, 1980-2009, presented at #EULAR2021. https://t.co/aZf6Ikpz18 https://t.co/2ZkYUCuxH6

Links:

Dr. John Cush RheumNow ( View Tweet)
×